VRTX AS OF 12/31/2014

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 12, 2015

Accession Number

0000080255-15-000306

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →